SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1
Abstract Chemoresistance is a severe outcome among patients with epithelial ovarian cancer (EOC) that leads to a poor prognosis. YBX-1 has been shown to cause treatment failure and cancer progression in EOC. However, strategies that directly target YBX-1 are not yet conceivable. Here, we identified...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2022-03-01
|
| Seri Bilgileri: | Oncogenesis |
| Online Erişim: | https://doi.org/10.1038/s41389-022-00387-6 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|